SCHEDULE 13G/A
SCHEDULE 13G/ASchedule 13G ownership disclosure
Tango Therapeutics Inc
Common stock, par value $0.001 per share (the "Shares") · CUSIP: 87583X109
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Farallon Capital Partners, L.P.
Shares: 1,792,415 · Class: 1.6%
- Farallon Capital Institutional Partners, L.P.
Shares: 2,301,057 · Class: 2.1%
- Farallon Capital Institutional Partners II, L.P.
Shares: 589,896 · Class: 0.5%
- Farallon Capital Institutional Partners III, L.P.
Shares: 417,567 · Class: 0.4%
- Four Crossings Institutional Partners V, L.P.
Shares: 505,935 · Class: 0.5%
- Farallon Capital Offshore Investors II, L.P.
Shares: 4,421,621 · Class: 4%
- Farallon Capital F5 Master I, L.P.
Shares: 425,421 · Class: 0.4%
- Farallon Capital (AM) Investors, L.P.
Shares: 303,088 · Class: 0.3%
- Farallon Partners, L.L.C.
Shares: 10,331,579 · Class: 9.3%
- Farallon Institutional (GP) V, L.L.C.
Shares: 505,935 · Class: 0.5%
- Farallon F5 (GP), L.L.C.
Shares: 425,421 · Class: 0.4%
- Dapice Joshua J.
Shares: 10,757,000 · Class: 9.7%
- Dreyfuss, Philip D.
Shares: 10,757,000 · Class: 9.7%
- Dunn Hannah E.
Shares: 10,757,000 · Class: 9.7%
- Fried, Richard B
Shares: 10,757,000 · Class: 9.7%
- Gehani, Varun N.
Shares: 10,757,000 · Class: 9.7%
- Giauque, Nicolas
Shares: 10,757,000 · Class: 9.7%
- Kim, David T.
Shares: 10,757,000 · Class: 9.7%
- Linn, Michael G.
Shares: 10,757,000 · Class: 9.7%
- Luo Patrick (Cheng)
Shares: 10,757,000 · Class: 9.7%
- Patel, Rajiv A.
Shares: 10,757,000 · Class: 9.7%
- Roberts, Jr., Thomas G.
Shares: 10,757,000 · Class: 9.7%
- Saito Edric C.
Shares: 10,757,000 · Class: 9.7%
- Seybold, William
Shares: 10,757,000 · Class: 9.7%
- Short Daniel S.
Shares: 10,757,000 · Class: 9.7%
- Spokes, Andrew J. M.
Shares: 10,757,000 · Class: 9.7%
- Warren, John R.
Shares: 10,757,000 · Class: 9.7%
- Wehrly, Mark C.
Shares: 10,757,000 · Class: 9.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-25-000328
- Form type
- SCHEDULE 13G/A
- Filer
- Farallon Capital Partners, L.P.
- CIK
- CIK 1175707
- Filed
- Nov 12, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership